This article is to be informative about the benefits of Molecular Hydrogen in counteracting the symptoms of arthritis.
The following clinical studies were conducted by independent research laboratories. These clinical studies suggest that arthritic symptoms can potentially be addressed with a monthly regimen of Hydrogen Water.
- muscle aches, pains, and tenderness;
- restriction in movement of the joint that can be worse in the morning or after physical activity;
- inability to use the hands or walk;
- permanent destruction of bone and cartilage;
- and poor sleep.
If you are one of millions with arthritis — decreased mobility and multiple symptoms could make it difficult to remain physically active, which can contribute to an increased risk of obesity, high cholesterol or vulnerability to heart disease, depression or fear, and premature death. While a decrease in physical activity can be an unfortunate result, arthritis can inevitably affect quality of life to the point of making a person home-bound. Arthritis is the most common cause of disability in the United States, especially arthritic disorders such as rheumatoid arthritis, psoriasis and lupus.
It has been hypothesized that Molecular Hydrogen could complement conventional therapy for arthritis. More than 600 research articles and numerous human trials have shown no side effects to be associated with Molecular Hydrogen; a key finding considering arthritis is often treated with conventional medications that often have side effects which are not well-tolerated.
The following scientific publications have indicated Hydrogen Water, by itself or in combination with conventional methods, can potentially benefit individuals with arthritis and other age-related inflammation.
A 2012 clinical study reported evidence from 20 arthritic individuals. A daily regimen (~500mL) of Hydrogen Water reduced their arthritic activity within four weeks. Arthritic activity continued to decrease over twelve weeks in all these individuals. Eighty percent (80%) showed significant improvement. Remission of all swollen or painful joints was observed for every individual who had early signs of arthritis and consumed Hydrogen Water.
In a follow-up 2014 clinical study of 24 arthritic people, these individuals were randomized to receive a daily regimen (~500mL) of either Molecular Hydrogen or a placebo. Molecular Hydrogen was reported to immediately decrease arthritic activity which continued to decrease over the course of four weeks – this effect was observed with the use of Molecular Hydrogen and not the placebo. Similar results were reported in a recent 2015 clinical study for individuals who had psoriasis-associated inflammation that is often associated with arthritis.
The safety profile has allowed Hydrogen Water to become available in the grocery market. The scientific team of HTWO has collaborated with the FDA to establish Molecular Hydrogen as “Generally Regarded as Safe (GRAS)” for infusion in beverages. The outcome is HTWO, the first Hydrogen Water introduced as a ready-to-drink beverage that is produced in the United States.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Copyright ©2015 HTWO Hydrogen Water. All rights reserved. www.HTWO.com